ATE475099T1 - Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) - Google Patents
Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor)Info
- Publication number
- ATE475099T1 ATE475099T1 AT05797120T AT05797120T ATE475099T1 AT E475099 T1 ATE475099 T1 AT E475099T1 AT 05797120 T AT05797120 T AT 05797120T AT 05797120 T AT05797120 T AT 05797120T AT E475099 T1 ATE475099 T1 AT E475099T1
- Authority
- AT
- Austria
- Prior art keywords
- hgf
- growth factor
- biological activity
- hepatocyte growth
- assessment
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62061004P | 2004-10-20 | 2004-10-20 | |
PCT/SE2005/001583 WO2006043892A1 (en) | 2004-10-20 | 2005-10-20 | Assessment of biological activity of hepatocyte growth factor (hgf) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE475099T1 true ATE475099T1 (de) | 2010-08-15 |
Family
ID=36203224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05797120T ATE475099T1 (de) | 2004-10-20 | 2005-10-20 | Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) |
Country Status (6)
Country | Link |
---|---|
US (1) | US20080261233A1 (de) |
EP (1) | EP1810037B1 (de) |
JP (1) | JP2008516629A (de) |
AT (1) | ATE475099T1 (de) |
DE (1) | DE602005022474D1 (de) |
WO (1) | WO2006043892A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101360511A (zh) * | 2005-11-16 | 2009-02-04 | 法里巴·内耶里 | 用内源c-met配体和抑制剂抑制个体中的癌发生和/或转移的方法 |
US8545839B2 (en) * | 2008-12-02 | 2013-10-01 | Pierre Fabre Medicament | Anti-c-Met antibody |
EP2446274B1 (de) | 2009-06-26 | 2017-08-09 | PEAS Institut AB | Verfahren zur bestimmung biologisch aktiver hgf |
GB2519329A (en) * | 2013-10-16 | 2015-04-22 | Gm Global Tech Operations Inc | Method of controlling an exhaust recirculation gas system |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000515735A (ja) * | 1996-07-03 | 2000-11-28 | ジェネンテック インコーポレーテッド | 肝細胞成長因子レセプターアゴニスト |
EP1320384B1 (de) | 2000-08-28 | 2007-10-10 | Damavand Wound AB | Die synergistischen wirkungen von hgf und antibakterieller behandlung |
US6818907B2 (en) * | 2000-10-17 | 2004-11-16 | The President And Fellows Of Harvard College | Surface plasmon enhanced illumination system |
SI2949658T1 (sl) * | 2003-03-03 | 2018-10-30 | Dyax Corp. | Peptidi, ki specifično vežejo HGF receptor (cMet) in njihove uporabe |
EP2367008A3 (de) | 2003-06-06 | 2014-12-24 | Genentech, Inc. | Modulierung der Interaktion zwischen HGF-beta-Kette und C-Met |
EP2292915B1 (de) | 2005-12-20 | 2013-07-24 | BorgWarner, Inc. | Steuerung zur Abgasrückführung in turboaufgeladenen Brennkraftmaschinen |
-
2005
- 2005-10-20 EP EP05797120A patent/EP1810037B1/de active Active
- 2005-10-20 WO PCT/SE2005/001583 patent/WO2006043892A1/en active Application Filing
- 2005-10-20 AT AT05797120T patent/ATE475099T1/de active
- 2005-10-20 JP JP2007537847A patent/JP2008516629A/ja active Pending
- 2005-10-20 DE DE602005022474T patent/DE602005022474D1/de active Active
- 2005-10-20 US US11/665,893 patent/US20080261233A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1810037B1 (de) | 2010-07-21 |
JP2008516629A (ja) | 2008-05-22 |
EP1810037A1 (de) | 2007-07-25 |
US20080261233A1 (en) | 2008-10-23 |
DE602005022474D1 (de) | 2010-09-02 |
WO2006043892A1 (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0507680A (pt) | partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas | |
IL180725A0 (en) | Inhibitors of angiopoietin-like 4 protein, combinations, and their use | |
ATE286118T1 (de) | Anwendungen für humane nicht autologe, mesenchymale stammzellen | |
IL190991A (en) | Causes of cardiac infarction and delay of left ventricular remodeling after cardiac infarction containing antibody that identifies IL-6 receptor as active substance | |
BRPI0618488A2 (pt) | proteìnas de fusão de ìntron de fator de crescimento de hepatócito | |
TW200505478A (en) | Immunoglobulin formulation and method of preparation thereof | |
NO20070293L (no) | Aryl-substituerte piperazinderivater | |
DE602006017071D1 (de) | Zusammensetzungen und verfahren zur behandlung von herzkrankheiten | |
ATE330468T1 (de) | Lösung zur evaluierung und konservierung | |
DE602005026105D1 (de) | Verwendung von agonisten und antagonisten von interleukin-33 (il-33) | |
BRPI0507812A (pt) | sistema de microativação, método para a microativação das células epidérmicas, kit, método para montar o dispositivo de microativação e método para a microativação da pele | |
SG196821A1 (en) | New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein | |
TW200616632A (en) | Compounds modulating c-kit activity and uses therefor | |
NO20070950L (no) | Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein. | |
ATE531383T1 (de) | Therapeutische verwendung eines wachstumsfaktors, metrnl | |
WO2007143098A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
BRPI0406605B8 (pt) | conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo | |
WO2007143090A3 (en) | Hepatocyte growth factor (hgf) binding proteins | |
SG161247A1 (en) | Variant forms of urate oxidase and use thereof | |
DE602005010246D1 (de) | Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration | |
DK1709161T3 (da) | Humane terapeutiske celler, som udskiller nervevækstfaktor | |
CY1118073T1 (el) | Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης | |
ATE512146T1 (de) | Phenylharnstoffderivate als hemmstoffe von tyrosinkinasen zur behandlung von tumorerkrankungen | |
WO2007005502A3 (en) | Methods and compositions for treating diseases targeting cdcp1 | |
DE60235234D1 (de) | Hydrogelkugeln oder kapseln als künstliches medium zur eiablage von insekten und zucht von endoparasitoiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1810037 Country of ref document: EP |